LIST OF BINDING INTERFACES for query 'PLASMINOGEN' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)
PDB Ligand Drug Indication Macromolecule/
Organism
Pfam Binding_Interfaces (View) Details
1b2i AMHTranexamic acid
(DB00302)
Tranexamic acid is an antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders.PROTEIN (PLASMINOGEN)
(Homo sapiens)
Kringle
1cea ACAAminocaproic acid
(DB00513)
Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.PLASMINOGEN
(Homo sapiens)
Kringle
1ceb AMHTranexamic acid
(DB00302)
Tranexamic acid is an antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders.PLASMINOGEN
(Homo sapiens)
Kringle
1f5l AMRAmiloride
(DB00594)
Amiloride is a pyrizine compound used to treat hypertension and congestive heart failure.UROKINASE-TYPE PLASMINOGEN ACTIVATOR
(Homo sapiens)
Trypsin
1pk2 ACAAminocaproic acid
(DB00513)
Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.TISSUE-TYPE PLASMINOGEN ACTIVATOR
(Homo sapiens)
Kringle
2pk4 ACAAminocaproic acid
(DB00513)
Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.HUMAN PLASMINOGEN KRINGLE 4
(Homo sapiens)
Kringle
6dcm ACAAminocaproic acid
(DB00513)
Aminocaproic acid is an antifibrinolytic agent used to induce clotting postoperatively.PLASMINOGEN
(Homo sapiens)
NA
6nmb AMHTranexamic acid
(DB00302)
Tranexamic acid is an antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders.UROKINASE-TYPE PLASMINOGEN ACTIVATOR
(Homo sapiens)
Trypsin
PDB Ligand Drug Indication Macromolecule/
Organism
Pfam Binding_Interfaces (View) Details